America Great Health (AAGH) Research

Operating as a U.S.-based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements. The company, which originated as Crown Marketing, adopted the name America Great Health in March 2017. Established in 2013, AAGH's headquarters are located in Alhambra, California.

Market snapshot

Symbol
AAGH
Price
$0.00
Day change
0.00%
Market cap
$4.2M
P/E ratio
-6.40x
52-week range
0.0001-0.001
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Ayala Pharmaceuticals, Inc. (ADXS)
  • Algernon Pharmaceuticals Inc. (AGNPF)
  • Agentix Corp. (AGTX)
  • Appili Therapeutics Inc. (APLIF)
  • Health Sciences Group, Inc. (HESG)
  • Universal Ibogaine Inc. (IBOGF)
  • Restart Life Sciences Corp. (NMLSF)
  • Regen BioPharma, Inc. (RGBP)

Open America Great Health (AAGH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.